Primary ovarian insufficiency with t(5;13): a case report and literature review on disrupted genes. (3rd September 2017)

• Record Type: Journal Article
• Authors: Mohamadhashem, F.; Rafati, M.; Hoseininasab, F.; Rostami, S.; Tabatabaie, R.; Rezai, S.; Keramatipour, M.; Ghaffari, S. R.
• Is Part Of: Climacteric. Volume 20:Number 5(2017)
• Page Start: 498
• Page End: 502
• Publication Date: 2017-09-03
• Subjects: Primary ovarian insufficiency -- premature ovarian failure -- reciprocal autosomal translocation -- 46, XX, t(5;13)(q13;q14); Menopause -- Periodicals; Menopause -- Hormone therapy -- Periodicals; Menopause -- Periodicals; Estrogen Replacement Therapy -- Periodicals; Gynecology -- Periodicals; Societies, Medical -- Periodicals; 612.665
• DOI: 10.1080/13697137.2017.1316255
• Languages: English
• ISSNs: 1369-7137

Abstract

Abstract: Objectives: To report a woman with primary ovarian insufficiency (POI) with reciprocal translocation between chromosomes 5 and 13. Methods: Chromosomal analysis (G-banding) of a 39-year-old woman with elevated gonadotropin levels and secondary amenorrhea and review of the literature with a special focus on disrupted genes at the reported breakpoints. Results: A reciprocal translocation between the long arms of chromosomes 5 and 13 was identified in the patient (46, XX, t(5;13)(q13;q14)). Investigation of the breakpoints revealed that the 13q14.1 region encompasses FOXO1 (forkhead box 1) gene, which has an important role in granulosa cell function and follicle maturation. Conclusions: Autosomal translocations are rare in women with POI. We have reported the first case of a de novo reciprocal translocation involving chromosomes 5 and 13 in a POI patient. As one of the breakpoints encompasses the FOXO1 gene, it seems that disruption of this gene can be the cause of POI in this patient. This provides further evidence on the role of autosomal translocations in disrupting POI-associated genes. Therefore, concentrating on the genes at the breakpoints will be helpful to delineate the new biological pathways or genes involved in POI pathogenesis.